Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2007

Jun 19, 2007

34519_dirs_2007-06-19_e979fea9-00f0-4f03-a76a-32330c54eb97.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2007-06-19

Reporting Person: Rhodes Linda (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-06-19 Common stock, $0.10 par value M 2000 $4.67 Acquired 2000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2007-06-19 Non-qualified stock option (Right to Buy) $4.67 M 2000 Disposed 2010-08-22 Common Stock (2000) Direct

Footnotes

F1: This option vests according to the following schedule, provided that Optionee is re-elected as a director at each such meeting:

 (i)  5,000 shares on and after the 2006 Annual Meeting of Shareholders;

 (ii)  an additional 5,000 shares on and after the 2007 Annual Meeting of Shareholders; and

 (iii)  the remaining 5,000 shares on and after the 2008 Annual Meeting of Shareholders.